Abbott Cardiac Rhythm Management
Founded Year
2018Stage
Other Investors | AliveAbout Abbott Cardiac Rhythm Management
Abbott Cardiac Rhythm Management specializes in the development of medical devices and solutions for treating cardiovascular conditions. The company offers a range of products that assist in cardiac rhythm management, vascular health, and heart failure monitoring, designed to improve patient outcomes and support healthcare professionals. These products are primarily utilized within the healthcare sector, including hospitals, clinics, and by healthcare professionals specializing in cardiovascular care. It was founded in 2018 and is based in Abbott Park, Illinois.
Loading...
Loading...
Abbott Cardiac Rhythm Management Frequently Asked Questions (FAQ)
When was Abbott Cardiac Rhythm Management founded?
Abbott Cardiac Rhythm Management was founded in 2018.
Where is Abbott Cardiac Rhythm Management's headquarters?
Abbott Cardiac Rhythm Management's headquarters is located at 100 Abbott Park Road., Abbott Park.
What is Abbott Cardiac Rhythm Management's latest funding round?
Abbott Cardiac Rhythm Management's latest funding round is Other Investors.
Who are the investors of Abbott Cardiac Rhythm Management?
Investors of Abbott Cardiac Rhythm Management include Heron Capital and ABHI US Accelerator.
Who are Abbott Cardiac Rhythm Management's competitors?
Competitors of Abbott Cardiac Rhythm Management include Ceryx Medical and 8 more.
Loading...
Compare Abbott Cardiac Rhythm Management to Competitors
Cardiosense offers a digital biomarker platform for the healthcare industry, specifically in cardiac care. The company provides wearable devices for continuous patient monitoring, software for managing and analyzing sensor data, and tools for early disease detection and personalized therapy. Cardiosense serves the healthcare sector with its focus on cardiac monitoring and disease prevention. It was founded in 2020 and is based in Chicago, Illinois.
Sensible Medical Innovations focuses on the monitoring and management of lung fluid in patients with chronic diseases such as heart failure. The company's product, ReDS, is a noninvasive system that provides measurements of lung fluid levels. Sensible Medical Innovations serves the healthcare sector, offering solutions related to patient care and medical decision-making. It was founded in 2007 and is based in Raleigh, North Carolina.
Crely focuses on healthcare technology, specifically in the domain of post-surgical care and monitoring. The company offers an artificial intelligence (AI)-based early warning system that utilizes a non-invasive, wearable medical device to predict and detect surgical site infections (SSIs) by monitoring patients' biomarkers remotely. Crely primarily serves the healthcare industry, including hospitals and care organizations. It was formerly known as Crely Healthcare. It was founded in 2017 and is based in Oxnard, California.
Eko focuses on digital health technologies within the healthcare sector. The company provides digital stethoscopes and an artificial intelligence detection platform, which assists healthcare professionals in detecting and monitoring heart and lung diseases. Eko Health serves the healthcare industry, with products intended for use by clinicians and health systems. Eko Health was formerly known as Eko Devices. It was founded in 2013 and is based in Emeryville, California.
Acorai focuses on developing medical devices within the healthcare sector, specifically targeting heart failure management. The company offers a non-invasive heart monitor that utilizes a combination of seismic, acoustic, visual, and electrocardiographic sensors, along with machine learning, to estimate intracardiac pressures for personalized treatment. It serves the healthcare sector. The company was founded in 2019 and is based in Helsingborg, Sweden.
Anumana is an AI-driven health technology company focused on transforming cardiac care through advanced analysis of electrical signals from the heart. The company offers AI solutions that enable earlier diagnosis of cardiovascular diseases and improve clinical decision-making in electrophysiology. Anumana's products are designed for integration into clinical workflows, for healthcare providers in early disease detection and intervention and enhancing patient safety and outcomes. It was founded in 2021 and is based in Cambridge, Massachusetts.
Loading...